Trevor Allred
Stock Analyst at Oppenheimer
(3.07)
# 1,321
Out of 5,076 analysts
4
Total ratings
100%
Success rate
57.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Trevor Allred
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences | Maintains: Outperform | $38 → $80 | $33.00 | +142.42% | 2 | Sep 23, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Outperform | $85 | $94.53 | -10.08% | 1 | Sep 9, 2025 | |
| INVA Innoviva | Initiates: Outperform | $35 | $21.16 | +65.41% | 1 | Aug 11, 2025 |
MBX Biosciences
Sep 23, 2025
Maintains: Outperform
Price Target: $38 → $80
Current: $33.00
Upside: +142.42%
Palvella Therapeutics
Sep 9, 2025
Initiates: Outperform
Price Target: $85
Current: $94.53
Upside: -10.08%
Innoviva
Aug 11, 2025
Initiates: Outperform
Price Target: $35
Current: $21.16
Upside: +65.41%